1.910USD-1.55%Mkt Cap: 2.78M $P/E: 0.232d ago
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The…
Industry Peers
Agricultural Inputs$52.42BUSDP/E 47.6
$35.06BUSDP/E 14.7
$18.01BUSDP/E 8.8
$10.31BUSDP/E 7.6
$7.07BUSD
$3.56BUSDP/E 23.6
$3.03BUSDP/E 2.6
$3.70BUSDP/E 21.7
$2.63BUSDP/E 15.4
$2.02BUSD
$1.33BUSD
$1.35BUSD
$1.29BUSDP/E 8.1
$540.63MUSD
$525.75MUSDP/E 12.2
$497.76MUSDP/E 31.3
$568.48MUSD
$449.93MUSDP/E 12.0
$330.51MUSDP/E 6.5
$135.59MUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
 Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS) Nexentis Technologies Inc. (NASDAQ:NXTS) shares advanced 10% on Monday after the company announced the partial monetisation of its investment in the Melz solar project in Germany, based on a project valuation of US$14. | ||
Top Midday Decliners Wheeler Real Estate Investment Trust (WHLR) said in a regulatory filing that it is marketing 35 of i | MMT Newswires | |
Top Midday Gainers Nexentis Technologies (NXTS) said Monday its subsidiary, MitoCareX Bio, has entered into an engageme | MMT Newswires | |